Cell-Free DNA Mutation Diagnostics Market to Surge to US$ 81,584.2 Million by 2034, Growing at a CAGR of 24.9% | Fact.MR Report [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
Rockville, MD , Dec. 05, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Cell-free DNA Mutation Diagnostics Market is estimated to reach a valuation of US$ 8,830.4 million in 2024 and is expected to grow at a CAGR of during the forecast period of (2024 to 2034). The global cell-free DNA mutation diagnostics market is set to experience exponential growth on the back of increasing demand in prenatal testing, oncology, & organ transplantation. PCR technologies and Next-generation sequencing (NGS) have been in a state of constant development by local players as well as by global manufacturers. The market is poised for a revolution in precision medicine by offering non-invasive solutions for early disease detection and real-time monitoring. The diagnostics of cfDNA have gained significant momentum as health providers and researchers move towards its non-invasive approach for the detection of mutation used in oncology a
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]Yahoo! Finance
- Macrogen Consortium win tender for National Bio Big Data ProjectPR Newswire
- Ovation.io and Illumina Collaborate to Advance Genomic Data ResearchBusiness Wire
- Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]Yahoo! Finance
- MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]Yahoo! Finance Canada
ILMN
Earnings
- 11/4/24 - Beat
ILMN
Sec Filings
- 1/2/25 - Form 4
- 12/9/24 - Form 4
- 12/6/24 - Form SC
- ILMN's page on the SEC website